AlAsmari, Abdullah F <br/><br/>
Liraglutide attenuates gefitinib-induced cardiotoxicity and promotes cardioprotection through the regulation of MAPK/NF-κB signaling pathways.  [electronic resource] 

 -  Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society  Apr 2020 
 - 509-518 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1319-0164 
<br/><br/><label>Standard No.: </label>10.1016/j.jsps.2020.03.002  doi